trending Market Intelligence /marketintelligence/en/news-insights/trending/jTNzeM5p_58mS-rVhra3XA2 content esgSubNav
In This List

Haemonetics names board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Haemonetics names board member

Haemonetics Corp. named Robert Abernathy to its board.

Abernathy is the former chairman and CEO of Halyard Health Inc.